Parkway Corporate Limited (PWN) AI Stock Analysis

• Market Cap: AU$38.74M
• Dividend Yield: N/A
• Average Volume (3M): 2.33M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.21
• Revenue Growth: 70.19%
• EPS Growth: N/A
• Country: AU
• Employees: N/A
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial Materials
• EPS (TTM): 0.00
• Shares Outstanding: 2,767,113,800
• 10 Day Avg. Volume: 1,701,155
• 30 Day Avg. Volume: 2,325,810
• PEG Ratio: -20.87
• Price to Book (P/B): 2.11
• Price to Sales (P/S): 2.19
• P/FCF Ratio: 60.09
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 53 Neutral
• Price Target: AU$0.00 ▼(-100.00% Downside)

The overall stock score is primarily influenced by financial performance concerns, particularly in profitability and cash flow generation. Technical analysis shows a positive trend, providing some support to the score. However, the lack of valuation metrics and earnings call data limits a comprehensive assessment.

Parkway Corporate Limited Business Overview & Revenue Model

Company Description

Parkway Corporate Limited (PWN) is a diversified company engaged in multiple sectors, primarily focusing on healthcare services, real estate, and technology solutions. The company operates a network of hospitals and healthcare facilities, providing high-quality medical care and specialized treatments. In addition to its healthcare operations, PWN is involved in real estate development and management, leveraging its expertise to create and manage commercial and residential properties. The technology division offers innovative software solutions aimed at improving operational efficiencies in healthcare and other industries.

How the Company Makes Money

Parkway Corporate Limited generates revenue through several key streams. Its healthcare services division earns money from patient admissions, surgeries, and outpatient services, benefiting from a strong brand reputation and a loyal customer base. The real estate sector contributes significantly through rental income from its property holdings and development projects, capitalizing on urban growth and demand for commercial space. Additionally, the technology solutions segment generates revenue through software licensing, subscription models, and consulting services, often in partnership with healthcare providers to enhance their operational capabilities. Strategic partnerships with insurance companies and government health programs also play a crucial role in driving revenue, as they facilitate patient referrals and reimbursements for services rendered.

Parkway Corporate Limited Financial Statement Overview

Summary

Parkway Corporate Limited demonstrates some revenue growth, but profitability and cash flow generation are areas of concern. The balance sheet is relatively stable, but the low return on equity indicates inefficiencies. The company needs to focus on improving operational efficiency and cash flow management to enhance its financial health.

Income Statement

Parkway Corporate Limited has shown a positive revenue growth rate of 6.34% in the latest year, indicating some improvement in sales. However, the gross profit margin is relatively low at 11%, and the net profit margin is marginal at 0.11%, suggesting limited profitability. The EBIT and EBITDA margins are also modest, reflecting operational challenges. Overall, while there is growth, profitability remains a concern.

Balance Sheet

The company's debt-to-equity ratio of 0.47 indicates a moderate level of leverage, which is manageable. The return on equity is very low at 0.10%, highlighting inefficiencies in generating returns for shareholders. The equity ratio stands at 60.27%, suggesting a stable capital structure with a significant portion of assets financed by equity. While the balance sheet shows stability, the low ROE is a concern.

Cash Flow

The free cash flow has decreased significantly by 57.47%, indicating potential liquidity issues. The operating cash flow to net income ratio is 0.31, suggesting that cash generation from operations is not strong. The free cash flow to net income ratio is 0.58, which is below ideal levels. Overall, the cash flow position is weak, with declining free cash flow and insufficient cash generation from operations.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	15.10M	15.14M	8.90M	4.25M	3.38M	327.30K
Gross Profit	3.23M	1.67M	2.43M	-789.45K	-1.19M	-1.06M
EBITDA	1.55M	1.61M	107.19K	-1.63M	-2.04M	-856.03K
Net Income	15.91K	15.91K	-734.41K	-1.68M	-2.33M	-923.72K
Balance Sheet
Total Assets	26.10M	26.10M	26.92M	11.96M	12.67M	12.97M
Cash, Cash Equivalents and Short-Term Investments	2.58M	2.58M	3.49M	2.00M	4.00M	7.45M
Total Debt	7.40M	7.40M	7.91M	2.80M	1.22M	494.99K
Total Liabilities	10.37M	10.37M	11.42M	3.80M	2.98M	1.10M
Stockholders Equity	15.73M	15.73M	15.49M	8.17M	9.69M	11.87M
Cash Flow
Free Cash Flow	552.57K	552.57K	470.83K	-1.74M	-3.43M	-2.73M
Operating Cash Flow	955.97K	955.97K	644.44K	-1.34M	-2.12M	-2.45M
Investing Cash Flow	-1.36M	-1.36M	-3.78M	-435.18K	-1.34M	1.33M
Financing Cash Flow	-510.87K	-510.87K	4.62M	-227.25K	12.87K	6.57M

Parkway Corporate Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.01
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:PWN, the sentiment is Positive. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 53.23 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:PWN.

Parkway Corporate Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
AMN	54 Neutral	€28.87M	-0.52	-87.86%	―	―	-727.17%
PWN	53 Neutral	AU$38.74M	―	<0.01%	―	70.19%	―
RVT	52 Neutral	AU$14.68M	-7.88	-4.46%	―	―	4.49%
PL9	45 Neutral	AU$37.66M	-33.33	―	―	―	96.00%
WAK	40 Neutral	AU$24.44M	-2.67	-106.72%	―	90.14%	52.54%
AW1	25 Underperform	AU$48.91M	―	―	―	―	7.16%

Parkway Corporate Limited Corporate Events

Parkway Corporate Limited Reports Strong Quarterly Performance and Strategic Progress

Parkway Corporate Limited reported strong quarterly performance with record free cash flow and ongoing strategic investments to enhance its engineering solutions capabilities. The company secured a 10-hectare site for its QBMC project and is progressing with formal approvals and feasibility activities. Parkway’s Industrial Operations division generated $3.62 million in operating revenue, contributing to a group EBITDA of $0.46 million, supported by specialized project execution activities. The company is building a project team for the QBMC project and scheduled an investor webinar to discuss its progress.

Parkway Corporate Limited Announces Proposed Issue of Securities

Parkway Corporate Limited announced a proposed issue of 7,500,000 unquoted performance rights, set to expire 10 years from the grant date, with a proposed issue date of December 10, 2025. This move is part of a placement or other type of issue, as the company seeks to enhance its financial strategies and potentially improve its market positioning.

Parkway Corporate Limited Announces Virtual AGM for 2025

Parkway Corporate Limited has announced its Annual General Meeting (AGM) for shareholders, scheduled to be held virtually on November 26, 2025. The company has opted to provide the Notice of Meeting and related materials electronically, encouraging shareholders to participate and vote online. This approach reflects Parkway’s commitment to leveraging technology for enhanced shareholder engagement and operational efficiency.

Parkway Corporate Limited Announces Virtual AGM for November 2025

Parkway Corporate Limited has announced that its Annual General Meeting (AGM) will be held virtually on November 26, 2025. Shareholders are encouraged to participate and vote, with the meeting set to discuss the company’s annual reports and a resolution on the remuneration report. The AGM is a significant event for stakeholders as it provides an opportunity to review the company’s financial performance and governance practices, potentially impacting future strategic decisions.

Parkway Corporate Limited Announces AGM Date and Director Nominations Deadline

Parkway Corporate Limited has announced the date for its Annual General Meeting, set for November 26, 2025, where the election of directors will be a key agenda item. The deadline for director nominations is October 6, 2025. This announcement highlights Parkway’s ongoing commitment to governance and strategic leadership as it continues to focus on its core operations in water and wastewater treatment technology. The meeting is expected to impact the company’s strategic direction and stakeholder engagement.

Parkway Corporate Limited Achieves Profitability with Record Revenue in FY25

Parkway Corporate Limited has announced a significant transition to profitability, achieving a maiden full-year net profit of $0.02 million for FY25, supported by record revenue of $15.14 million. The company anticipates continued growth in FY26, bolstered by substantial contracted project revenues and strategic investments in its industrial and technology divisions, which are expected to enhance its market position as a leading provider of wastewater treatment solutions.

Parkway Corporate Limited Releases Updated Corporate Governance Statement

Parkway Corporate Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement, approved by the board and current as of September 23, 2025, outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations. This announcement highlights Parkway’s commitment to transparency and accountability in its governance practices, providing stakeholders with insights into the company’s management and oversight structures.

Parkway Corporate Limited Strengthens Corporate Governance Framework

Parkway Corporate Limited has committed to implementing high standards of corporate governance by aligning with the ASX Corporate Governance Council’s Principles and Recommendations. The company has adopted a Corporate Governance Plan, outlining the roles and responsibilities of the board and management, which is available on its website. The board’s primary role is to govern the company, ensuring compliance with legal obligations and driving company performance. This initiative aims to enhance the company’s operational effectiveness and stakeholder engagement, although full compliance with all recommendations will be pursued as the company grows.

Parkway Corporate Limited’s 2025 Annual Report: A Focus on Innovative Water Solutions

Parkway Corporate Limited’s 2025 Annual Report highlights its strategic focus on commercializing innovative water and wastewater treatment technologies. This approach is aimed at tackling global sustainability challenges, potentially enhancing the company’s market position and offering significant benefits to stakeholders.